期刊文献+

THY1基因在卵巢上皮性癌组织中的表达

Expression of THY1 Gene in Epithelial Ovarian Cancer
原文传递
导出
摘要 目的检测人正常卵巢组织、卵巢浆液性囊腺瘤和浆液性囊腺癌组织中THY1蛋白的表达,探讨其表达变化与卵巢浆液性囊腺癌患者临床病理因素间的关系。方法应用免疫组化法,检测25例人正常卵巢组织、25例卵巢浆液件囊腺瘤组织和53例浆液性囊腺癌组织中THYI蛋白的表达。结果THY1蛋向在正常卵巢、卵巢浆液性囊腺瘤和浆液性囊腺癌组织中的阳性表达率分别为60.0%(15/25)、72.0%(18/25)和34.0%(18/53),IOD值分别为288449.2±60087.3、271655.6±66588.7和252087.6±45559.4。卵巢浆液性囊腺癌中,THY1蛋门的阳性表达率明显低于正常卵巢和卵巢浆液性囊腺瘤组织(P〈0.05),且THY1蛋白的表达景与卵巢浆液性囊腺痴的手术一病理分期、组织学分级及淋巴结转移旱显著负相关(均P〈0.05)。结论THY1基因的缺失町能与卵巢浆液性囊腺癌的发生、发展相关。 Objective To detect the cxpession of THY1 in ovarian serous cystadenocarcinoma tissues. Methods Immnunohistochemistry was performed to detect the expression of THY1 gene in formalinfixed, paraffin-embedded specimens of normal ovaries ( n = 25 ), ovarian serous cystadenoma ( n= 25 ) , and serous cystadenocarclnoma ( n = 53 ). The correlation of THYI expression with clinicopathological parameters was statistically analyzed. Results The positive expression rates of THY1 protein in normal ovaries, ovarian serous cystadenomas and ovarian serous cystadenocarcinomas were 60.0% (15/25), 72.0% (18/25) and 34.0% ( 18/53 ) , respectively. The values of IOD of THY1 protein expression were 288 449.2 ± 60 087.3, 271 655.6 ± 66 588.7 and 252 087.6 ± 45 559.4, respectively. The expression of THY1 protein was significantly down-regulated in ovarian serous cystadenocarcinoma tissues compared with that in normal ovarian tissues and ovarian serous cystadenoma tissues (P 〈0.05 ). THY1 expression was negatively correlated with surgical-pathological staging, histological differentiation and lymph node involvement (P 〈 0.05). Conclusion The decreased level of THY1 expression may be related with the occurrence and development of ovarian serous cystadenocarcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第2期118-120,共3页 Chinese Journal of Oncology
基金 2008年度广东省医学科研基金(A2008099)
关键词 卵巢肿瘤 罐因 THY1 基因 临床病理学 Ovarian neoplasms Gene, THY1
  • 相关文献

参考文献10

  • 1Abeysinghe HR, Cao Q, Xu J, et al. THY1 expression is associated with tumor suppression of human ovarian cancer. Cancer Genet Cytogenet, 2003, 143 : 125-132.
  • 2于萍,步宏,王华,赵高平,张景丽,周桥.免疫组化结果的图像分析与人工计数方法的对比研究[J].生物医学工程学杂志,2003,20(2):288-290. 被引量:188
  • 3Abeysinghe HR, Pollock SJ, Guckert NL, et al. The role of THY1 gene in human ovarian cancer suppression based on transfection studies. Cancer Genet Cytogenet, 2004, 149:1-10.
  • 4Barker TH, Grenett HE, MacEwen MW, et al. Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and RhoGTPase activity. Exp Cell Res, 2004, 295:488-496.
  • 5Diaz-Romero J, Gaillard JP, Grogan SP, et al. Immunophenotypie analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J Cell Physiol, 2005, 202:731-742.
  • 6Lung HL, Bangarusamy DK, Xie D, et al. THY1 is a candidate turnout suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oneogene, 2005, 24:6525-6532.
  • 7陈晋峰,张力建,赵爱莲,王歈,吴楠,熊宏超,梁震,李吉友,黄信孚,杨跃.Thy-1肿瘤标记物在肺癌组织中的异常表达及其对肺癌患者预后的影响[J].中华医学杂志,2005,85(27):1921-1925. 被引量:7
  • 8Cao Q, Abeysinghe H, Chow O, et al. Suppression of tumorigenicity in human ovarian carcinoma cell line SKOV-3 by microcell-mediated transfer of chromosome 11. Cancer Genet Cytogenet, 2001, 129:131-137.
  • 9曾俐琴,彭芝兰.THY1基因对上皮性卵巢癌细胞SKOV3生长的抑制作用[J].南方医科大学学报,2007,27(1):84-87. 被引量:4
  • 10Einhorn N, NilssonB, Sjovall K. Factors influencing survival in carcinoma of the ovary: study from a well-defined Swedish population. Cancer, 1985, 55:2019-2025.

二级参考文献14

  • 1熊正文.免疫组织化学技术中抗原修复的研究进展[J].中华病理学杂志,1997,26(2):124-126. 被引量:74
  • 2Pervez T.Cancer ovary,present and future of management[J].J Ayub Med Coll Abbottabad,2003,15(2):65-8.
  • 3Abeysinghe HR,Cao Q,Xu J,et al.THY1 expression is associated with tumor suppression of human ovarian cancer[J].Cancer Genet Cytogenet,2003,143(2):125-32.
  • 4Abeysinghe HR,Pollock SJ,Guckert NL,et al.The role of THY1 in human ovarian cancer suppression by transfection studies[J].Cancer Genet Cytogenet,2004,149(1):1-10.
  • 5Davis M,Hitchcock A,Foulkes WD,et al.Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer[J].Cancer Res,1996,56(4):741-4.
  • 6Mason JC,Yarwood H,Tarnok A,et al.Human Thy-1 is cytokineinducible on vascular endothelial cells and is a signaling molecular regulated by protein kinase C[J].J Immunol,1996,157(2):874-83.
  • 7Reif AE,Allen JM.The AKR thymic antigen and its distribution in leukemias and nervous tissue[J].J Exp Med,1964,120:413-33.
  • 8Crawford JM,Barton RW.THY1 glycoprotein:structure,distribution and ontogeny[J].Lab Invest,1986,54(2):122-35.
  • 9Barker TH,Pallero MA,MacEwen MW,et al.Thrombospondin-1-induced focal adhesion disassembly in fibroblasts requires Thy-1 surface expression,lipid raft integrity,and Src activation[J].J Biol Chem,2004,279(22):23510-16.
  • 10Tentori L,Pardoll DM,Zuniga JC,et al.Proliferation and production of IL-2 and B cell stimulatory factor Ⅰ/IL-4 in early fetal thymocytes by activation through THY1 and CD3[J].J Immunol,1998,140(4):1089-94.

共引文献195

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部